DeepHealth will present research at RSNA 2026 highlighting AI portfolio's breadth and impact on cancer detection, risk assessment and imaging workflows.
The consensus price target hints at a 25.1% upside potential for RadNet (RDNT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
AlphaCore Capital LLC bought a new position in shares of RadNet, Inc. (NASDAQ: RDNT) in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 12,338 shares of the medical research company's stock, valued at approximately $851,000. A number of other
RadNet's advanced imaging mix is improving as faster scanners help its centers handle more complex exams. Their DeepHealth software has also secured larger external contracts, which shows it can sell well beyond RDNT's own centers. In that sense, ONRAD's hospital relationships should give RDNT yet another route to sell DeepHealth alongside radiology services.
I assign a "Buy" rating to RadNet, Inc. following a substantial 3Q2026 earnings beat and a value-enhancing ONRAD acquisition. RDNT's advanced imaging mix shift, operating leverage, and AI-driven cost controls are driving margin expansion and profit outperformance. The ONRAD acquisition enables inpatient market penetration and immediate geographic expansion and is expected to be margin-accretive given ONRAD's >30% EBITDA margins.
RadNet, Inc. ( RDNT ) Q3 2026 Earnings Call November 9, 2026 10:30 AM EST Company Participants Mark Stolper - Executive VP & CFO Howard Berger - Chairman, President & CEO Cornelis Wesdorp - President & CEO of Digital Health Sham Sokka - Chief Operating and Technology Officer of Digital Health Conference Call Participants Brian Tanquilut - Jefferies LLC, Research Division Clarke Murphy - Truist Securities, Inc., Research Division Andrew Mok - Barclays Bank PLC, Research Division Matthew Gillmor - KeyBanc Capital Markets Inc., Research Division Yuan Zhi - B. Riley Securities, Inc., Research Division James Sidoti - Sidoti & Company, LLC Presentation Operator Good morning, and welcome to the RadNet, Inc. Third Quarter 2026 Financial Results Conference Call.
RadNet NASDAQ: RDNT reported record third-quarter revenue and adjusted EBITDA as demand for advanced imaging, acquisitions and growth in its Digital Health business helped drive results. The company also raised its full-year outlook for its imaging center segment.
While the top- and bottom-line numbers for RadNet (RDNT) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.